Approving additional brands of Covid-19 vaccines in South Africa would help counter any future disruptions in the country’s vaccine roll-out.
This, according to Professor Gregory Hussey, of the Faculty of Health Sciences, at the University of Cape Town.
Hussey welcomed the news that, except for the Johnson & Johnson and Pfizer-vaccines, other brands of vaccines may soon be introduced here.
He says the global demand for vaccines will, for a while still, cause strain on vaccine-supply to especially African countries.
The Department of Health recently said that the Sinovac vaccine has been provisionally approved for use in the country, while the Astra-Zeneca may also, in future, be used here again.
Access the latest Western Cape digicon here.
- Athlone Stadium Mass Covid-19 Vaccination Site has opened to walk-ins, drive-through to be added in next few weeks.
- Western Cape wants to increase vaccine-demand among residents.
- Western Cape healthcare system under severe pressure but has capacity to treat Covid-19 patients.
📢Covid-19 vaccination update
Yesterday, 17 August 2021, we administered 34 694 vaccines and our total vaccines administered have now surpassed 1.5 million, bringing the total to 1 531 319 to date. #LetsDoThis pic.twitter.com/MZ896SwBUP
— Premier Alan Winde (@alanwinde) August 18, 2021
— Premier Alan Winde (@alanwinde) August 13, 2021
The World Health Organization (WHO) has approved China’s Sinovac Covid-19 vaccine for emergency use.
The Organization says it will now be able to significantly boost its supply of vaccines to the Covax-facility, after green-lighting the use of the vaccine.
The WHO’s prof. Katherine O’Brien says clinical trials have shown that up to 51% of people – vaccinated with Sinovac – developed a less severe form of the virus.
O’Brien says this is the second Chinese vaccine, after Sinopharm, to receive WHO-approval.
Read more here.
- WHO concerned about increase in Covid-19 infections in sub-Saharan African countries.
- [Listen]: W.H.O calls for international Pandemic Treaty.
- WHO: Surge in Covid-19 infections contributes to shortfall in Covid-19 vaccine-doses to Covax-facility.
— World Health Organization (WHO) (@WHO) June 3, 2021